AU2001266055A1 - Screening method for modulators of suv39h2-methyltransferase - Google Patents

Screening method for modulators of suv39h2-methyltransferase

Info

Publication number
AU2001266055A1
AU2001266055A1 AU2001266055A AU6605501A AU2001266055A1 AU 2001266055 A1 AU2001266055 A1 AU 2001266055A1 AU 2001266055 A AU2001266055 A AU 2001266055A AU 6605501 A AU6605501 A AU 6605501A AU 2001266055 A1 AU2001266055 A1 AU 2001266055A1
Authority
AU
Australia
Prior art keywords
suv39h2
modulators
methyltransferase
screening method
methyltransferase activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001266055A
Inventor
Thomas Jenuwein
Donal O'carroll
Stephen Rea
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP00112479A external-priority patent/EP1162460A1/en
Priority claimed from EP00112345A external-priority patent/EP1162274A1/en
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of AU2001266055A1 publication Critical patent/AU2001266055A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91005—Transferases (2.) transferring one-carbon groups (2.1)
    • G01N2333/91011—Methyltransferases (general) (2.1.1.)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Murine and human Suv39h2 polypeptide and DNA molecules encoding them. <i>Suv39h2</i> is a novel member of the <i>Suv3-9</i> gene family. Suv39h2 is a novel component of meiotic higher order chromatin. It has histone methyltransferase activity and is required, in combination with Suv39h1, for male gametogenesis. Sub39h2 can be used in screening methods to identify modulators of its methyltransferase activity, which are useful in cancer therapy and for male contraception.
AU2001266055A 2000-06-09 2001-06-08 Screening method for modulators of suv39h2-methyltransferase Abandoned AU2001266055A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP00112345 2000-06-09
EP00112479A EP1162460A1 (en) 2000-06-09 2000-06-09 Mammalian Suv39h2 proteins and isolated DNA molecules encoding them
EP00112345A EP1162274A1 (en) 2000-06-09 2000-06-09 Method for identifying compounds modifying methyltransferase-dependent chromosome stability
EP00112479 2000-06-09
PCT/EP2001/006520 WO2001094621A1 (en) 2000-06-09 2001-06-08 Screening method for modulators of suv39h2-methyltransferase

Publications (1)

Publication Number Publication Date
AU2001266055A1 true AU2001266055A1 (en) 2001-12-17

Family

ID=26071033

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001274088A Abandoned AU2001274088A1 (en) 2000-06-09 2001-06-07 Screening-method for modulators of methyltransferase-dependent chromosome stability
AU2001266055A Abandoned AU2001266055A1 (en) 2000-06-09 2001-06-08 Screening method for modulators of suv39h2-methyltransferase

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2001274088A Abandoned AU2001274088A1 (en) 2000-06-09 2001-06-07 Screening-method for modulators of methyltransferase-dependent chromosome stability

Country Status (7)

Country Link
EP (2) EP1294927B1 (en)
JP (2) JP4896344B2 (en)
AT (1) ATE310100T1 (en)
AU (2) AU2001274088A1 (en)
DE (1) DE60115039T2 (en)
ES (1) ES2252240T3 (en)
WO (2) WO2001094620A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002359916A1 (en) * 2001-12-27 2003-07-15 Takeda Chemical Industries, Ltd. Preventives/remedies for cancer
GB0301450D0 (en) * 2003-01-22 2003-02-19 Medical Res Council Protein crystal structure
JP3913181B2 (en) * 2003-02-06 2007-05-09 三菱重工業株式会社 Carbon nanofiber manufacturing method and manufacturing apparatus
JP5451376B2 (en) * 2007-03-15 2014-03-26 株式会社リバース・プロテオミクス研究所 Biomarkers specific for blood cell lineage or specific for osteoclast differentiation
JP6064231B2 (en) * 2011-06-03 2017-01-25 オンコセラピー・サイエンス株式会社 SUV39H2 as a target gene for cancer treatment and diagnosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011667A1 (en) * 1997-08-29 1999-03-11 Innogenetics N.V. METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS

Also Published As

Publication number Publication date
AU2001274088A1 (en) 2001-12-17
JP2003535595A (en) 2003-12-02
EP1294927A1 (en) 2003-03-26
JP2003535596A (en) 2003-12-02
ATE310100T1 (en) 2005-12-15
JP4896344B2 (en) 2012-03-14
DE60115039D1 (en) 2005-12-22
DE60115039T2 (en) 2006-07-27
EP1294927B1 (en) 2005-11-16
WO2001094620A1 (en) 2001-12-13
WO2001094621A1 (en) 2001-12-13
ES2252240T3 (en) 2006-05-16
EP1294928A1 (en) 2003-03-26

Similar Documents

Publication Publication Date Title
AU3897897A (en) Methods and apparatus for the application of combined fields to disinfect fluids
AU2002210980A1 (en) Laser therapy method, highly laser beam-absorbing media to be used in the therapy and laser therapy apparatus with the use of the same
AU2189400A (en) Insertion sets with micro-piercing members for use with medical devices and methods of using the same
HK1091228A1 (en) Methods for making recombinant proteins using apoptosis inhibitors
AU2905897A (en) Quinoline carboxamides as tnf inhibitors and as pde-iv inhibitors
AU3206095A (en) Neural cell adhesion molecules, nucleotide sequences encoding the molecules, and methods of use thereof
HK1028615A1 (en) Isolated nona-and decapeptides which bind to hla molecules, and the use thereof
WO2001061017A3 (en) Modified cytokines for use in cancer therapy
AU2003299661A1 (en) Fuel cell assemblies and methods of making the same
AU5874798A (en) Vaccination methods and molecules
AU2001266055A1 (en) Screening method for modulators of suv39h2-methyltransferase
GB9825096D0 (en) Cells,culture methods and their uses
AU3522089A (en) Combination of angiotensin converting enzyme inhibitors with potassium channel modulators and use thereof in pharmaceuticals
AU1705599A (en) Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral blood
AU2002251533A1 (en) Protein involved in restoration of cytoplasmic male sterility to fertility and gene encoding the protein and gene
AU2003228817A1 (en) Human adipocyte cell populations and methods for identifying modulators of same
AU2003247537A1 (en) Chd5 encoding nucleic acids, polypeptides, antibodies and methods of use thereof
AU2002258525A1 (en) Telomerase expression repressor proteins and methods of using the same
EP0757104A4 (en) Medium for microbiological examination and method of microbiological examination with the use of the same
WO2004041297A3 (en) Modified cytokines for use in cancer therapy
EP0733057A4 (en) Origin of replication complex genes, proteins and methods
AU2003260815A1 (en) Method for the rapid assessment of the presence and viability of bacterial cells and use thereof________________________
AU9694798A (en) T cell receptor-associated molecules (trams) and methods of use therefor
AU3028900A (en) Ras activator nucleic acid molecules, polypeptides and methods of use
WO2001042431A3 (en) Regulation of human mitochondrial deformylase